Maternal Pre-Pregnancy Glycemic Status and Growth Delay in Korean Children Aged 18-36 Months: A Population-Based

Eun-Jung Oh1, Yeeun Han2, Tae-Eun Kim3

  • 1Department of Family Medicine, Konkuk University Medical Center, Chungju Hospital, Konkuk University School of Medicine, Chungju 27376, Republic of Korea.

PubMed

Insights

Maternal pre-pregnancy diabetes mellitus (DM) and impaired fasting glucose (IFG) are linked to delayed growth in children. Optimizing maternal glycemic control before pregnancy is crucial for healthy child development.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Public Health

Background:

  • Maternal pre-pregnancy glycemic status is a critical factor influencing fetal development and long-term child health.
  • Understanding the association between maternal hyperglycemia and offspring growth is essential for early intervention strategies.
  • Nationwide health screening data provides a robust platform for investigating population-level health trends.

Purpose of the Study:

  • To evaluate the association between maternal pre-pregnancy glycemic status (normal, impaired fasting glucose, diabetes mellitus) and offspring growth delay.
  • To assess the impact of maternal hyperglycemia on visual and auditory development in children.
  • To identify potential risks for delayed child development linked to maternal glycemic control.

Main Methods:

  • Retrospective cohort analysis of 258,367 mother-child dyads born between 2014-2021.
  • Categorization of maternal glycemic status: normal (<100 mg/dL), impaired fasting glucose (IFG, 100-125 mg/dL), diabetes mellitus (DM, ≥126 mg/dL).
  • Growth delay defined as <10th percentile for height, weight, head circumference; visual/auditory development assessed via questionnaires; weighted relative risks (RRs) calculated.

Main Results:

  • Prevalence of growth delay: 3.5% (height), 3.8% (weight), 4.3% (head circumference). Visual/auditory issues reported in 1.2% and 8.2% of children.
  • Both DM (1.2%) and IFG (9.3%) groups exhibited increased risks of growth delay in offspring across assessed age periods.
  • Maternal hyperglycemia was significantly associated with offspring's visual and auditory development, with observed age- and period-specific differences.

Conclusions:

  • Maternal pre-pregnancy glycemic status is significantly associated with delayed growth in Korean children aged 18-36 months.
  • The study underscores the critical importance of optimizing maternal glycemic control before conception.
  • Effective pre-pregnancy glycemic management is vital for promoting favorable child developmental outcomes and preventing growth delays.

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
691
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.1K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
3.2K